Qualys (QLYS) announced the Qualys Government Platform has achieved FedRAMP High Authorization, sponsored by the U.S. Drug Enforcement Agency. This authorization makes Qualys one of the few cybersecurity platforms offering a full-spectrum security solution at the FedRAMP High level and positions it among an elite group of vendors trusted to support the federal government’s most sensitive systems.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QLYS:
- Qualys: Balancing Strategic Strengths and Growth Challenges Amidst Evolving Market Dynamics
- Qualys Inc. Shines in Q2 2025 Earnings Call
- Qualys Positioned for Growth: Strong Performance and Strategic Initiatives Justify Buy Rating
- Cautious Outlook for Qualys: Hold Rating Amid Modest Billings Growth and Strategic Initiatives
- Qualys price target raised to $150 from $142 at Scotiabank